Zentalis Pharmaceuticals
ZNTL
#8945
Rank
A$0.15 B
Marketcap
$2.14
Share price
-3.52%
Change (1 day)
-87.70%
Change (1 year)

Operating Margin for Zentalis Pharmaceuticals (ZNTL)

Operating Margin at the end of 2024: -245.74%

According to Zentalis Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -245.73%. At the end of 2024 the company had an Operating Margin of -245.74%.

Operating Margin history for Zentalis Pharmaceuticals from 2018 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-245.74%
2018-167,342.86%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-8,391.15% 3,314.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.45%-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.